United States
Germany
Japan
United Kingdom
China
SLAMF7 mouse monoclonal antibody, clone OTI3B3 (formerly 3B3)
| Applications | FC, IHC, WB |
| Reactivities | Human |
Products
SLAMF7 mouse monoclonal antibody, clone OTI1F1 (formerly 1F1)
| Applications | FC, IHC, WB |
| Reactivities | Human |
SLAMF7 mouse monoclonal antibody, clone OTI1A5
| Applications | FC, WB |
| Reactivities | Human |
SLAMF7 mouse monoclonal antibody, clone OTI3B6
| Applications | FC, WB |
| Reactivities | Human |
SLAMF7 mouse monoclonal antibody, clone OTI5H5
| Applications | FC, WB |
| Reactivities | Human |
SLAMF7 mouse monoclonal antibody, clone OTI3B3 (formerly 3B3)
| Applications | FC, IHC, WB |
| Reactivities | Human |
SLAMF7 mouse monoclonal antibody, clone OTI3E3 (formerly 3E3)
| Applications | FC, WB |
| Reactivities | Human |
SLAMF7 mouse monoclonal antibody, clone OTI1F1 (formerly 1F1)
| Applications | FC, IHC, WB |
| Reactivities | Human |
SLAMF7 mouse monoclonal antibody, clone OTI1A5
| Applications | FC, WB |
| Reactivities | Human |
SLAMF7 mouse monoclonal antibody, clone OTI5H5
| Applications | FC, WB |
| Reactivities | Human |
SLAMF7 mouse monoclonal antibody, clone OTI3B6
| Applications | FC, WB |
| Reactivities | Human |
SLAMF7 mouse monoclonal antibody, clone OTI3E3 (formerly 3E3)
| Applications | FC, WB |
| Reactivities | Human |
